BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29409694)

  • 1. Effective concentration of intravenous immunoglobulin for neutralizing Panton-Valentine leukocidin in human blood.
    Tanaka J; Hirayama F; Yanase S; Uno S; Nakae T; Kamizono A; Hanaki H
    J Infect Chemother; 2018 May; 24(5):383-388. PubMed ID: 29409694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection.
    Hermos CR; Yoong P; Pier GB
    Clin Infect Dis; 2010 Nov; 51(10):1138-46. PubMed ID: 20946065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of the Staphylococcus aureus Panton-Valentine leukocidin by African and Caucasian sera.
    Grebe T; Rudolf V; Gouleu CS; Löffler B; Adegnika AA; Shittu AO; Deinhardt-Emmer S; Niemann S; Schaumburg F
    BMC Microbiol; 2022 Sep; 22(1):219. PubMed ID: 36115948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro.
    Gauduchon V; Cozon G; Vandenesch F; Genestier AL; Eyssade N; Peyrol S; Etienne J; Lina G
    J Infect Dis; 2004 Jan; 189(2):346-53. PubMed ID: 14722901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.
    Yoong P; Pier GB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2241-6. PubMed ID: 20133867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of bacterial virulence by antibody neutralization of immune-activating toxins.
    Yoong P
    Virulence; 2010; 1(5):409-13. PubMed ID: 21178480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus.
    Cardot-Martin E; Casalegno JS; Badiou C; Dauwalder O; Keller D; Prévost G; Rieg S; Kern WV; Cuerq C; Etienne J; Vandenesch F; Lina G; Dumitrescu O
    Lett Appl Microbiol; 2015 Aug; 61(2):158-64. PubMed ID: 25963798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of monoclonal antibodies generated against Panton-Valentine Leukocidin (PVL-S) toxin for specific identification of community acquired methicillin resistance Staphylococcus aureus.
    Poojary NS; Ramlal S; Urs RM; Sripathy MH; Batra HV
    Microbiol Res; 2014 Dec; 169(12):924-30. PubMed ID: 24935729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of pvl-positive community-onset methicillin-resistant Staphylococcus aureus isolated at a university hospital in Japan.
    Nakaminami H; Ito A; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H; Noguchi N
    J Infect Chemother; 2017 Dec; 23(12):856-858. PubMed ID: 28655502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
    Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
    Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of SCCmec types and Panton-Valentine leukocidin in community-acquired and nosocomial Staphylococcus aureus strains: comparing skin and soft tissue infections to the other infections].
    Gülmez D; Sancak B; Ercis S; Karakaya J; Hasçelik G
    Mikrobiyol Bul; 2012 Jul; 46(3):341-51. PubMed ID: 22951646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Panton Valentine Leukocidin (PVL) genes with methicillin resistant Staphylococcus aureus (MRSA) in Western Nepal: a matter of concern for community infections (a hospital based prospective study).
    Bhatta DR; Cavaco LM; Nath G; Kumar K; Gaur A; Gokhale S; Bhatta DR
    BMC Infect Dis; 2016 May; 16():199. PubMed ID: 27179682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical expression, invasiveness and outcome of
    Petraitiene B; Conejo PR; Jankauskaite L; Kevalas R; Trumpulyte G; Snipaitiene A; Vitkauskiene A; Gurskis V
    Infect Dis (Lond); 2020 Jul; 52(7):464-472. PubMed ID: 32297537
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular characterization of community- & hospital-acquired methicillin-resistant & methicillin-sensitive Staphylococcus aureus isolates in Sikkim.
    Bhutia KO; Singh T; Adhikari L; Biswas S
    Indian J Med Res; 2015 Sep; 142(3):330-5. PubMed ID: 26458350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology.
    Zaidi T; Zaidi T; Yoong P; Pier GB
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4430-8. PubMed ID: 23737477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin.
    Brown EL; Bowden MG; Bryson RS; Hulten KG; Bordt AS; Forbes A; Kaplan SL
    Clin Vaccine Immunol; 2009 Jan; 16(1):139-41. PubMed ID: 19005019
    [TBL] [Abstract][Full Text]